Adverse event reports submitted to the FDA, describing the actual or potential contamination of a reprocessed flexible endoscope, have increased significantly over the past seven years, according to a review and analysis.
The report, released in January by Lawrence Muscarella, PhD, the president of LFM Healthcare Solutions and a national authority on the causes and prevention of healthcare-related